News
ARDX
1.840
+3.95%
0.070
Dollar Tree, Dycom Industries, Chico's FAS And Other Big Losers From Tuesday
Benzinga · 4d ago
Why InMed Pharmaceuticals Shares Tumbled 28%; Here Are 67 Biggest Movers From Friday
Benzinga · 6d ago
Foot Locker, Ross Stores, Palo Alto Networks, And Other Big Gainers From Friday
Benzinga · 6d ago
Why PaxMedica Shares Are Trading Higher By Over 53%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
Benzinga · 11/18 18:15
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 11/18 17:31
Ardelyx (ARDX) Up 41% After FDA Committee Endorses CKD Drug
The FDA's CRDAC recommends granting marketing approval to Ardelyx's (ARDX) oral pill to control serum phosphorus in adult patients with chronic kidney disease on dialysis.
Zacks · 11/18 15:14
Analyst Sees This Kidney Disease Company's Stock Could Rise Sixfold, But Lists Two Issues
Benzinga · 11/18 11:43
Why Inotiv Shares Dipped 57%; Here Are 76 Biggest Movers From Yesterday
Benzinga · 11/18 10:14
Hillenbrand, Cisco, Macy's And Other Big Gainers From Thursday
Benzinga · 11/18 07:43
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 11/17 21:32
Nasdaq Down 60 Points; Alibaba Posts Upbeat Q2 Earnings
Benzinga · 11/17 19:32
Why Elevate Credit Shares Are Trading Higher By Over 71%? Here Are 43 Stocks Moving In Thursday's Mid-Day Session
Benzinga · 11/17 18:20
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 11/17 17:32
Looking Into Ardelyx's Recent Short Interest
Benzinga · 11/17 17:10
S&P 500 Down 1%; Crude Oil Drops Sharply
Benzinga · 11/17 17:07
Insider Buy: Ardelyx
Insider Buy: Ardelyx
MT Newswires · 11/17 16:26
Why Is CytomX Therapeutics (CTMX) Stock Up 29% Today?
Investor Place · 11/17 15:47
Why Is Ardelyx (ARDX) Stock Up 38% Today?
Investor Place · 11/17 15:25
Ukraine Asserts It Does Not Take Blame For Poland Missile Attack, Crypto Exchange Gemini Suffers $485M In Outflows, FTX, Bahamas Regulator Lock Horns Over Control Of Bankruptcy Proceedings: Top Stories Thursday, Nov. 17
Benzinga · 11/17 13:54
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 11/17 13:07
More
Webull provides a variety of real-time ARDX stock news. You can receive the latest news about Ardelyx through multiple platforms. This information may help you make smarter investment decisions.
About ARDX
Ardelyx, Inc. is a biopharmaceutical company. The Company focuses on discovery, development, and commercialization of advanced medicines that meet significant unmet medical needs. The Company's product pipeline includes IBSRELA (tenapanor), XPHOZAH, RDX013 Program, and RDX020 Program. Tenapanor is a small molecule therapy in development for the treatment of hyperphosphatemia, a condition of elevated levels of phosphate in the blood, common among patients with chronic kidney disease (CKD) on dialysis. Tenapanor has a mechanism of action and acts locally in the gut to inhibit the sodium hydrogen exchanger 3 (NHE3). IBSRELA is developed for the treatment of patients with irritable bowel syndrome with constipation (IBS-C). XPHOZAH is a medicine for the control of serum phosphorus in adult patients with CKD on dialysis. RDX013 Program is a small molecule potassium secretagogue program for the treatment of hyperkalemia. RDX020 Program is a small molecule for treating metabolic acidosis.